03 october 2016
Video interview of Stanislas Veillet, CEO of Biophytis. Click here to see it
Video interview of Stanislas Veillet, CEO of Biophytis. Click here to see it
Business Update and Consolidated Half-Year Financials as of June 30, 2016. Read the Press Release
BIOPHYTIS launches the second phase of Sarconeos pharmacokinetics study (SARA-PK) after successful completion of the initial phase. Read the Press Release
BIOPHYTIS ready to launch SARA-OBS trial. Read the Press Release
Biophytis will be present at BIOPHARM AMERICA 2016 in Boston, from September 13 to 15
BIOPHYTIS will present at the Rodman & Renshaw 18th Annual Global Investment Conference In New York City, September 11-13, 2016. Read the Press Release
Enrollment of the first subjects in the pharmacokinetics study on Sarcopenia. Read the Press Release
BIOPHYTIS receives approval of bpifrance for an innovation loan of €1.1M to finance the SARA-PK trial. Read the press release
BIOPHYTIS receives Belgian regulatory authorization to start Sarconeos pharmacokinetics study in elderly healthy volunteers (SARA-PK). Read the Press Release
Results of the Combined General Shareholders’ Meeting held on June 10, 2016. Read the Press Release